ELV Elevance Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELV

Price (delayed)

$377.68

Market cap

$81.91B

P/E Ratio

16.68

Dividend/share

$6.86

EPS

$22.64

Enterprise value

$102.72B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 45

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The company's revenue rose by 6% YoY
ELV's quick ratio is up by 4.5% since the previous quarter and by 4.5% year-on-year
ELV's P/E is 18% above its last 4 quarters average of 14.1 but 3% below its 5-year quarterly average of 17.2
Elevance Health's debt has increased by 2.8% YoY but it has decreased by 2.5% from the previous quarter
Elevance Health's net income has decreased by 7% YoY and by 5% QoQ
Elevance Health's EPS has decreased by 4.2% QoQ and by 4.2% YoY
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.antheminc.com
Peers: OSCR PFG

Key stats

What are the main financial stats of ELV

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
-0.43%
1 week
1.22%
1 month
-1.65%
1 year
34.68%
YTD
7.74%
QTD
-2.34%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$201.11B
Gross profit
$30.41B
Operating income
$7.3B
Net income
$4.96B
Gross margin
15.1%
Net margin
2.5%
The operating margin has declined by 18% year-on-year and by 5% since the previous quarter
The operating income has contracted by 13% YoY and by 4.4% from the previous quarter
Elevance Health's net margin has decreased by 11% YoY and by 3.8% from the previous quarter
Elevance Health's net income has decreased by 7% YoY and by 5% QoQ

Price vs fundamentals

How does ELV's price correlate with its fundamentals

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
ELV P/E details
P/E
16.68
P/B
1.83
P/S
0.41
EV/EBIT
14.04
EV/EBITDA
11.63
EV/Sales
0.51
ELV's P/E is 18% above its last 4 quarters average of 14.1 but 3% below its 5-year quarterly average of 17.2
Elevance Health's EPS has decreased by 4.2% QoQ and by 4.2% YoY
ELV's price to book (P/B) is 30% lower than its 5-year quarterly average of 2.6 but 8% higher than its last 4 quarters average of 1.7
The equity has increased by 2.7% YoY and by 2.2% from the previous quarter
ELV's P/S is 32% below its 5-year quarterly average of 0.6 but 2.5% above its last 4 quarters average of 0.4
The company's revenue rose by 6% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's ROIC has decreased by 20% YoY and by 6% from the previous quarter
Elevance Health's return on sales has decreased by 18% YoY and by 5% QoQ
Elevance Health's return on assets has decreased by 11% YoY and by 7% QoQ
ELV's ROE is down by 10% YoY and by 7% QoQ

Dividends

What is ELV's dividend history
Dividend details
DPS
$6.86
Dividend yield
1.82%
Payout ratio
30.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Elevance Health financials performed over time
The total assets is 55% higher than the total liabilities
The current ratio rose by 6% YoY and by 2.7% QoQ
ELV's quick ratio is up by 4.5% since the previous quarter and by 4.5% year-on-year
Elevance Health's debt is 31% less than its equity
The debt to equity has declined by 5% since the previous quarter
The equity has increased by 2.7% YoY and by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.